Antibiotic resistance poses a serious threat to modern medical practice mak
ing treatment more difficult and is associated with increased mortality amo
ng patients infected with resistant organisms. There is clear evidence that
acquisition of resistance is associated with a decrease in the fitness of
the organisms at least in the short term. Evidence from in vitro experiment
s indicates that bacteria have the ability to adapt to this deficit and rec
over fitness on serial passage. More recent results show that identical org
anisms isolated from patients in outbreaks have an initial deficit but that
adaptation occurs in vivo. Strategies directed towards controlling resista
nce must move beyond wishful thinking that supposes that these organisms wi
ll disappear merely with control of prescribing. In some cases, resistance
will not disappear because there is no evolutionary disadvantage in being r
esistant once adaptation has taken place. It is important. therefore. that
we direct out efforts towards preventing primary resistance emerging and in
limiting the spread of resistant strains. Ultimately, we must look again t
o new drug discovery to improve our therapeutic armoury. (C) 2001 Elsevier
Science B.V. and International Society of Chemotherapy All rights reserved.